Executive Team

Gulati, Martha_Cedars_Cropped V2


Martha Gulati, MD, MS, FACC, FAHA, FASPC

Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC was a Professor of Medicine and the inaugural Chief of Cardiology at the University of Arizona. She is the author of the best-seller, “Saving Women’s Hearts”. She served as the chair of the national chest pain guidelines that were released in late 2021. She joined the Cedars-Sinai Heart Institute in 2022 as a professor of cardiology and is the director of prevention, the associate director of the Barbra Streisand Women's Heart Center and holds the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research.

Her exceptional commitment to the study of women and cardiac diseases has won her numerous awards and distinctions, including being named by Crain’s Chicago Business as one of Chicago’s Top 40 under 40. In 2011, she received the first CREDO (Coalition to Reduce Racial and Ethnic Disparities in Cardiovascular Outcomes) Award from the American College of Cardiology that was given to honor her contributions to improve cardiovascular healthcare of women patients. In 2012, she was awarded the National Red Dress Award for her efforts in raising awareness of heart disease in women and advancing research in this field. In 2019, she was chosen as the most influential woman in Arizona and received the 2019 American College of Cardiology’s Bernadine Healy Award for her leadership and accomplishment in the field of cardiovascular disease in women.

She is the principal investigator of the St. James Women Take Heart Project, a study examining cardiac risk factors in women, which set standards for women’s fitness levels and heart rate response to exercise in women.  She also is a co-investigator on the Women Ischemic Syndrome Evaluation (WISE) and previously served as a co-investigator on the Women’s Health Initiative (WHI).  She has published articles in peer-reviewed publications, including The New England Journal of Medicine, Circulation, and Journal of the American Medical Association (JAMA).  She has also been featured on Oprah.

Dr. Gulati is Canadian and completed medical school at the University of Toronto, Canada.  She went on to complete her internship, residency and cardiology fellowship at the University of Chicago.  She received a Masters’ in Science at the University of Chicago and is a fellow of the American College of Cardiology, the American Heart Association, the American Society for Preventive Cardiology & the European Society of Cardiology.  She is board certified in cardiovascular disease.



Michael Shapiro, DO, FASPC

Michael Shapiro is the inaugural Fred M. Parrish Professor of Cardiology and Molecular Medicine at Wake Forest University where he is on faculty in the Section of Cardiovascular Medicine. After completing a cardiology fellowship, Michael spent two additional years in a clinical and research fellowship focused on advanced cardiovascular imaging at Massachusetts General Hospital/Harvard Medical School. After training, he was on faculty in the Knight Cardiovascular Institute at Oregon Health & Science University. He served as Director of Atherosclerosis Imaging and Associate Director of the Center for Preventive Cardiology. In 2019, he transitioned to Wake Forest University where he serves as the Director of the Center for Prevention of Cardiovascular Disease and the Co-Director of the NIH T32 Cardiovascular Disease Epidemiology and Prevention Research Fellowship Program.

Michael's clinical interests focus on genetic and acquired disorders of cholesterol and triglycerides, atherosclerosis Imaging, genetic predisposition to early myocardial infarction, and cardiovascular risk assessment in apparently healthy individuals. Michael has published extensively in the areas of atherosclerosis imaging, lipid disorders, and preventive cardiology. His current investigative research focuses on PCSK9 physiology and its impact on lipoprotein metabolism. Other areas of research include metabolomics of atherosclerosis, development and validation of automated quantification of breast arterial calcification as a means to refine cardiovascular risk estimation in women, and implementation of machine learning algorithms to identify individuals with familial hypercholesterolemia. He is an established Multiethnic Study of Atherosclerosis and Diabetes Heart Study investigator. He also serves as a principal investigator on numerous clinical trials testing novel lipid modulating therapeutics. Michael is a member of numerous boards and national committees related to preventive cardiology, familial hypercholesterolemia, and lipid disorders.



David Maron, FASPC

Dr. Maron is Director of Preventive Cardiology. He is board certified in internal medicine, cardiovascular disease, and clinical lipidology. He was an undergraduate at Stanford, received his medical degree from University of Southern California, and completed his residency in internal medicine at UCLA. He completed a cardiology fellowship and a research fellowship in cardiovascular disease epidemiology and prevention at Stanford University as a Robert Wood Johnson Clinical Scholar. He was on the faculty at Vanderbilt for 20 years before returning to Stanford in 2014. His research is focused on primary and secondary prevention of coronary artery disease. He has extensive experience in multicenter clinical trials, serving as a member of the Executive Committee and Chair of the Optimal Medical Therapy Committee for the VA-funded COURAGE trial, and now as the PI and Co-Chair of the NHLBI-funded ISCHEMIA trial, and Co-Chair of the NHLBI-funded ISCHEMIA-CKD trial.

Bailey, Alison


Alison L. Bailey, MD, FACC, FASPC

Alison L. Bailey, MD, FACC, FASPC, is chief of cardiology for Centennial Heart at Parkridge Medical Center in Chattanooga, Tennessee and a Physician Director of Cardiovascular Disease for HCA Healthcare. Her clinical practice focuses on the prevention of cardiovascular disease, women’s cardiovascular care and the diagnosis and treatment of heart failure.

She is passionate about medical education and has been involved with the design and delivery of cardiovascular education for over 10 years. She has served as cardiovascular disease fellowship program director, developed education curricula for GME and clinical practice improvement and bedside education.

She currently serves as the editor-in-chief of the American College of Cardiology's Extended Learning (ACCEL) editorial board, is the immediate past governor of the ACC's Tennessee Chapter and a board member for the American Society of Preventive Cardiology.


Immediate Past President

Peter P. Toth, MD, PhD, FASPC

Dr. Toth received his B.A. in Biochemistry from Princeton University and a Ph.D. in Biochemistry from Michigan State University. He graduated from Wayne State University School of Medicine and completed residency training at the University of Iowa Hospitals and Clinics. He is a member of Alpha Omega Alpha and Sigma Xi. He is a past president of the National Lipid Association and the American Board of Clinical Lipidology. He is the President of the American Society for Preventive Cardiology. He is a fellow of the American College of Cardiology, European Society of Cardiology, American Society of Preventive Cardiology, and the American Heart Association. Dr. Toth has authored and coauthored over 400 publications in medical and scientific journals and textbooks. He is Series Editor of Springer’s textbook collection in Contemporary Cardiology. He has edited and written 19 textbooks on various aspects of cardiovascular medicine. He has lectured on many topics in cardiovascular medicine throughout the world.